Recently, the wife of a patient with a pancreatic cancer asked “Why were there no symptoms?” A good question and very often asked by many. The pancreas is an organ that sits right at the back of your abdomen. It is very deep and therefore is very difficult to feel on examination. Ultrasound scan of the upper abdomen, though frequently done for health screening, can find it difficult to visualise the entire pancreas because the air in the over-lying intestine obscures the view of the pancreas. When you do develop symptoms such as jaundice or intractable back pain, the pancreatic cancer is usually quite large or advanced. Hence many patients with pancreatic cancer would have inoperable cancer when they first present to the doctor or surgeon. However, there will be a group of patients who, at presentation, will have a borderline resectable pancreatic cancer. In most instances they would be offered chemotherapy or symptomatic treatment only. But should that be the case?
Researchers from the Texas MD Anderson Cancer Center reported their experience with treating patients with borderline resectable pancreatic cancer (J Am Coll Surg 2008 206: 833 - 846). These patients were: patients with tumour abutting on the visceral arteries or short-segment occlusion of the superior mesenteric vein, patients with findings suggestive but not diagnostic of metastasis and patients with marginal performance status. All these patients were treated initially with chemotherapy, chemoradiation or both and then reassessed for surgery. Between October 1999 and August 2006, they had 160 patients with borderline resectable pancreatic cancer. One hundred and twenty patients completed therapy and were restaged. Of these 125 patients, 66 (41% of the original 160 patients) underwent surgery to remove the pancreatic cancer. The study showed that the median survival for these 66 patients was 40 months. For the 94 patients who had chemotherapy / chemoradiation but did not have surgery to remove the pancreatic cancer, the median survival was only 13 months.
While many pancreatic cancers at diagnosis are clearly not operable, there are some patients who are clearly operable and some who are borderline operable. Operability or borderline operability can only be decided upon by a pancreatic surgeon. Once the surgeon has determined that it is borderline operability, the medical oncologist and surgeon will need to work closely together so that a proportion of patients will be able to undergo surgery to remove the pancreatic cancer, thus giving these patients a chance to survive much longer.
